TRIMTECH Therapeutics

To add a bio or update company history, please click update information.

News from TRIMTECH Therapeutics

TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments

5 Mar 2025

TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments

TRIMTECH Therapeutics develops targeted protein degradation medicines that selectively remove harmful protein aggregates, focusing on neurodegenerative and inflammatory diseases with limited existing treatment options.

TRIMTECH Therapeutics

Life Sciences
Cambridge, United Kingdom
£24m
trimtechtherapeutics.com
Update Information

More venture news

Ternary Therapeutics
16 Mar 2026
Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences
BIOCAPTIVA
9 Mar 2026
BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
EquityLife Sciences
LifeCellsNI
4 Mar 2026
LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility
Pre-seedLife Sciences

TRIMTECH Therapeutics

News from TRIMTECH Therapeutics

TRIMTECH raises £24m seed led by Cambridge Innovation Capital and SV Health Investors to advance neurodegenerative treatments

More venture news

Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy

LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility